Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin for Cerebral Venous Thrombosis: An Updated Systematic Review and Meta-analysis (P3-5.010)

Key Points

• This research aims to assess the safety and efficacy of direct oral anticoagulants compared to warfarin for cerebral venous thrombosis.
• Conducted a systematic review and meta-analysis of existing studies comparing DOACs and warfarin.
• Included various studies evaluating treatment outcomes for CVT using DOACs or warfarin.
• DOACs demonstrated comparable efficacy to warfarin for treating CVT with a lower incidence of major bleeding events.
• Findings suggest that DOACs are potentially safer, making them a viable alternative to warfarin for CVT treatment.